PJPayam Jannatdoust

Payam Jannatdoust

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Payam Jannatdoust has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Feasibility of treating neuroendocrine prostate cancer with anti-SSTR radioligands: A systematic review of imaging and treatment studies

    by Parya Valizadeh, Payam Jannatdoust, Mehrnoosh Shahgholianghahfarokhi, Pedram Heidari, Yusuf Menda, Ahmad Shariftabrizi

  • CT Emphysema and Deep Learning–derived Vertebral Bone Loss in Individuals without COPD: Findings from MESA

    by Elena Ghotbi, Quincy A. Hathaway, Payam Jannatdoust, Roham Hadidchi, Michael P. Bancks, David A. Bluemke, Matthew Budoff, Wendy Post, Eric A. Hoffman, Benjamin M. Smith, et al.

    Among adults without chronic obstructive pulmonary disease, quantitative subclinical emphysema-like changes at chest CT were associated with accelerated thoracic vertebral bone loss over time, especially in men.

  • Post‐Transplant Ultrasound Findings in Pediatric Kidney Recipients: A Longitudinal Experience From the Children's Medical Center (2018–2024)

    by Parya Valizadeh, Mastaneh Moghtaderi, Payam Jannatdoust, Fatemeh Zamani, Fahimeh Askarian, Arash Abbasi, Behnaz Bazargani, Shirin Djalalinia, Daryoush Fahimi

    Background and Objectives: Ultrasonography is routinely used after pediatric kidney transplantation, but the prevalence and longitudinal pattern, and prognostic value of abnormal findings are not well defined. We described the frequency and temporal trends of post‐transplant ultrasound abnormalities in children and evaluated their association with graft outcomes. Methods: We retrospectively included patients (< 18 years) who underwent kidney transplantation at Children's Medical Center Hospital between 2018 and 2024. Sonographic features (parenchymal changes, peritransplant collections, urinary tract abnormalities, and Doppler indices) were recorded within six predefined follow‐up windows. We used descriptive statistics and Kaplan–Meier survival curves stratified by the presence of any abnormal ultrasound finding at each window. Analyses were performed in R (version 4.3). Results: Sixty‐three patients (mean age 12.0 ± 3.9 years) were included. Abnormal findings were present in 43%–56% of scans across follow‐up windows. Peritransplant collections (33.9%) and hematomas (24.6%) were common early findings, whereas hydronephrosis and increased echogenicity became more frequent over time. Resistive index elevation (> 0.8) was uncommon (< 3.5%). Three‐year graft survival was 55.7%. Any abnormality on baseline ultrasound was associated with lower 36 month survival (40.9% vs. 73.1%, log‐rank p = 0.025), while abnormalities detected at later windows were not associated with survival differences. Conclusion: Abnormal ultrasound findings were common after pediatric kidney transplantation, particularly in the early postoperative period. Baseline abnormalities were associated with poorer long‐term graft survival, which may reflect perioperative complications or early allograft injury. This supports the clinical value of baseline ultrasound for early risk stratification and guiding the follow‐up intensity.

  • Diagnostic performance of intravoxel incoherent motion imaging in evaluating sacroiliitis activity in axial spondyloarthritis: a meta-analysis

    by Parya Valizadeh, Payam Jannatdoust, Kimia Darmiani, Peyman Mirghaderi, Rachael Stovall, Majid Chalian

    Objectives: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease affecting the sacroiliac joints. MRI detects inflammation, but conventional sequences are non-quantitative. Intravoxel incoherent motion (IVIM) imaging quantifies diffusion and perfusion without contrast agents and may address this limitation. We evaluated whether IVIM parameters distinguish active from inactive sacroiliitis and from healthy controls. Methods: This systematic review and meta-analysis followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Literature searches in Web of Science, PubMed, Embase, and Scopus identified studies reporting the diagnostic performance of IVIM parameters, Dslow (pure diffusion), Dfast (pseudodiffusion), and perfusion fraction (f), for sacroiliitis, up to August 2025. Pooled sensitivity, specificity, and area under the curve (AUC) were calculated with a bivariate random-effects model; heterogeneity with I2. Results: Six studies comprising 541 participants (178 active sacroiliitis, 277 inactive sacroiliitis, 86 healthy controls) were included. Dslow demonstrated the highest accuracy for differentiating active from inactive sacroiliitis (Sensitivity: 86.3%, Specificity: 88.1%, AUC: 0.93) and from healthy controls (Sensitivity: 89.3%, Specificity: 96.3%, AUC: 0.98). Diagnostic accuracy declined for distinguishing inactive sacroiliitis from controls (AUC: 0.72). Dfast and f showed lower diagnostic performances. Conclusion: Clinically, IVIM—especially Dslow—may serve as a non-contrast adjunct for activity stratification and follow-up; confirmation requires prospective multicentre studies with pre-specified thresholds, direct comparisons with apparent diffusion coefficient and dynamic contrast-enhanced MRI, and assessment of management and cost impact. Advances in knowledge: This is the first study to meta-analyse and systematically review IVIM for SpA activity monitoring. It confirms the potential capability of IVIM—especially Dslow—as a potential imaging biomarker.

  • Ultrasound-based machine learning models for predicting response to neoadjuvant chemotherapy in breast cancer: A meta-analysis

    by Parya Valizadeh, Payam Jannatdoust, Niloofar Moradi, Shirin Yaghoobpoor, Sajjad Toofani, Nazanin Rafiei, Farzan Moodi, Hamed Ghorani, Arvin Arian


  • Differentiating malignant from benign splenic lesions: a meta-analysis and pictorial review of imaging features

    by Parya Valizadeh, Payam Jannatdoust, Mohammadreza Tahamtan, Soroush Soleimani Dorcheh, Fattaneh Khalaj, Hamed Ghorani, Niloofar Ayoobi Yazdi, Faeze Salahshour

    Objectives Splenic lesions might exhibit overlapping imaging features, varying from benign entities like cysts and hemangiomas to malignancies such as lymphoma and angiosarcoma. This meta-analysis aims to delineate imaging characteristics that distinguish malignant from benign splenic lesions. Methods Adhering to PRISMA guidelines, we searched PubMed, Scopus, and Web of Science for studies on imaging features differentiating malignant from benign splenic lesions. We extracted data on splenic pathology and imaging characteristics and assessed the methodological quality via QUADAS-2. Odds ratio meta-analyses were performed using STATA (Version 17.0, Stata Corp, College Station, TX). Results Portal phase hypoenhancement, hypovascular enhancement pattern, diffusion restriction, and late phase hypoenhancement, with odds ratios above 10, highly indicate malignancy. Other features suggestive of malignancy include solid morphology, lymphadenopathy, presence of perisplenic fluid, arterial hypoenhancement, hypoechogenicity on ultrasound, splenomegaly, and presence of multiple lesions. In contrast, cystic morphology, hypervascular-washout and hypervascular-persistent pattern of enhancement, late phase hyperenhancement, anechogenicity on ultrasound, portal phase hyperenhancement, well-defined borders, and calcification are in favour of benign pathology. Conclusion The study underscores the critical role of contrast-enhanced and diffusion-weighted imaging in distinguishing malignant from benign splenic lesions, emphasizing the role of features like portal phase hypoenhancement and restricted diffusion in diagnosing malignancies. Additionally, the study emphasizes the value of contrast-enhanced ultrasound, which allows for the visualization of key contrast-enhancement patterns without the risk of ionizing radiation exposure. Graphical abstract


  • Open Access

    Quantitative analysis of lung lesions using unenhanced chest computed tomography images

    by Fariba Zarei, Payam Jannatdoust, Siamak Malekpour, Mahshad Razaghi, Sabyasachi Chatterjee, Vani Varadhan Chatterjee, Amirbahador Abbasi, Rezvan Ravanfar Haghighi

    Introduction: Chest radiograph and computed tomography (CT) scans can accidentally reveal pulmonary nodules. Malignant and benign pulmonary nodules can be difficult to distinguish without specific imaging features, such as calcification, necrosis, and contrast enhancement. However, these lesions may exhibit different image texture characteristics which cannot be assessed visually. Thus, a computer‐assisted quantitative method like histogram analysis (HA) of Hounsfield unit (HU) values can improve diagnostic accuracy, reducing the need for invasive biopsy.Methods: In this exploratory control study, nonenhanced chest CT images of 20 patients with benign (10) and cancerous (10) lesion were selected retrospectively. The appearances of benign and malignant lesions were very similar in chest CT images, and only pathology report was used to discriminate them. Free hand region of interest (ROI) was inserted inside the lesion for all slices of each lesion. Mean, minimum, maximum, and standard deviations of HU values were recorded and used to make HA.Results: HA showed that the most malignant lesions have a mean HU value between 30 and 50, a maximum HU less than 150, and a minimum HU between −30 and 20. Lesions outside these ranges were mostly benign.Conclusion: Quantitative CT analysis may differentiate malignant from benign lesions without specific malignancy patterns on unenhanced chest CT image.


  • Open Access

    Machine learning approaches in the prediction of positive axillary lymph nodes post neoadjuvant chemotherapy using MRI, CT, or ultrasound: A systematic review

    by Shirin Yaghoobpoor, Mobina Fathi, Hamed Ghorani, Parya Valizadeh, Payam Jannatdoust, Arian Tavasol, Melika Zarei, Arvin Arian


  • Open Access

    Diagnostic performance of different imaging modalities for splenic malignancies: A comparative meta-analysis

    by Parya Valizadeh, Payam Jannatdoust, Mohammadreza Tahamtan, Hamed Ghorani, Soroush Soleimani Dorcheh, Khashayar Farnoud, Faeze Salahshour